This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Hospital Clinic De Barcelona, The United States of America, as Represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wurzburg, DE (2020 - 2023)
- Würzburg, DE (2021 - 2023)
Company Filing History:
5 out of 27 
5 out of 3,697 
4 out of 66 
Years Active: 2020-2023
Title: The Innovative Contributions of Andreas Rosenwald
Introduction
Andreas Rosenwald is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of lymphoma research, holding three patents that focus on methods for diagnosing and treating various types of lymphoma. His work has the potential to greatly impact patient care and treatment options.
Latest Patents
Rosenwald's latest patents include a method for determining lymphoma type and providing treatment. This invention offers a way to distinguish between different lymphoma types based on gene expression measurements. Specifically, it can differentiate between primary mediastinal B cell lymphoma (PMBCL) and diffuse large B cell lymphoma (DLBCL) using gene expression signatures. Furthermore, it can identify subtypes of DLBCL, which can be crucial for tailoring treatment approaches.
Another significant patent is directed towards subtyping lymphoma types through expression profiling. This method allows for the selection of treatment options for various lymphoma subjects, including activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) and germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL). By analyzing digital gene expression data obtained from biopsy samples, this invention enhances the precision of lymphoma treatment.
Career Highlights
Throughout his career, Rosenwald has worked with prestigious institutions, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Hospital Clinic de Barcelona. His experience in these organizations has contributed to his expertise in lymphoma research and treatment methodologies.
Collaborations
Rosenwald has collaborated with esteemed colleagues, including Louis M. Staudt and George W. Wright. These partnerships have likely enriched his research and led to advancements in the understanding of lymphoma.
Conclusion
Andreas Rosenwald's innovative work in lymphoma research exemplifies the impact of scientific inquiry on medical treatment. His patents not only advance the field but also hold promise for improving patient outcomes in lymphoma care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile